Pfizer Inc., US7170811035

Pfizer stock slips to EUR 26.18, down 0.61% premarket

Published on 11/17/2026 at 08:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Pfizer develops medicines and vaccines across several therapeutic areas. On Xetra, the stock closed at EUR 26.34 on Monday, November 16, 2026.

What Pfizer Investors Should Watch

  • Pfizer develops medicines and vaccines across several therapeutic areas.
  • The next quarterly results are expected around February 5, 2027.
Pfizer Inc., US7170811035, Illustration mit AI erstellt.

Pfizer stock traded at EUR 26.18 on Lang & Schwarz at 08:43 CET on Tuesday, November 17, 2026, 0.61% below the Xetra close of Monday, November 16, 2026.

Pfizer develops medicines and vaccines across several therapeutic areas, with research, manufacturing and global distribution supporting its biopharmaceutical business, according to Pfizer.

Ploutos AI places Pfizer's next quarterly results around February 5, 2027.

Broader market direction can be followed through the S&P 500.

More news and analyses on Pfizer stock

Disclaimer...
en | US7170811035 | PFIZER INC. | boerse | 70525461 | bgmi